Assessment of Katphala tvak churna nasya in Chronic sinusitis: An exploratory study

Assessment of Ekal dravya Katphala (Myrica nagi Thumb.) tvak churna nasya in Dushta pratishyaya (Chronic sinusitis): An exploratory study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055152

Enrollment

Registered

2023-07-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Katphala (Myrica nagi Thumb.) tvak churna: 7days (approx. 500mg) Katphala (Myrica nagi Thumb.) tvak churna nasya f/b 7days gap period f/b 7days (approx. 500mg) Katphala (Myrica nagi T

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects within age group 21-50 years irrespective of gender, caste and religion. 2. Patients having symptoms of nasal discharge, nasal blockage, local pain, headache, nasal stuffiness, anosmia etc as per Lakshans of Dushta pratishyaya. 3. Those subjects who will be ready to sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Subjects not willing for trial & follow up. 2. Patients with coexisting nasal conditions other than chronic rhinitis e.g. nasal polyposis, acute sinusitis and sinonasal tumors. 3. Patients with previous surgery to the nasal cavity or sinuses. 4. Patients taking steroids or other immunosuppressive treatment. 5. Pregnant women or lactating mothers. 6. Patients who had had an upper respiratory tract or sinus infection that required antibiotic therapy within 14 days prior to recruitment, or those who had a viral upper respiratory tract infection (URTI) within seven days prior to recruitment. 7. Patients with a history of blood borne infections. 8. Patients with any clinically significant metabolic, cardiovascular, immunological, neurological,hematological, gastrointestinal, cerebrovascular or respiratory disease, or any other disorder which, in the judgment of the investigators, might interfere with the study evaluations or affect patient safety.

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of Dushta Pratishyaya (Chronic sinusitis) i.e Nasa Strava and Nasa Avarodha in adult patients of chronic sinusitis after 21 days of trial.Timepoint: On day 1st,21st and follow up.	—

Secondary

Measure	Time frame
1. Reduction in remaining signs and symptoms in adult patients of chronic sinusitis after 21 days of trial. 2. The changes in investigations.Timepoint: On day 1st,21st and follow up.	—

Countries

India

Contacts

Public ContactDr NARAYANA BAVALATTI

ALL INDIA INSTITUTE OF AYURVEDA

tnesari@hotmail.com9958817145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026